South China. Sci. Total Environ. 452-453, 365-376. 108. Kelessidis A, Stasinakis AS. 2012 Comparative study of 122. Carlsson G, Orn S, Larsson DGJ. 2009 Effluent from Ps
(doi:10.1016/.scitotenv.2013.03.010) the methods used for treatment and final disposal of bulk drug production is toxic to aquatic vertebrates. »
98. Holloway KA. 2011 Promoting the rational use of sewage sludge in European countries. Waste Manage. Environ. Toxicol. Chem. 28, 2656-2662. (doi:10. 8
antibiotics. Reg. Health Forum 15, 122-130. 32, 1186-1195. (doi:10.1016/j.wasman.2012.01.012) 1897/08-524.1) 3
99. Xu Wet al. 2013 Antibiotics in riverine runoff of the 109. CIA 2014 The world factbook. Central Intelligence 123. Gaw S, Thomas KV, Hutchinson TH. 2014 Sources, &
earl River Delta and Pearl River Estuary, China: Agency, Office of Public Affairs. See https:/www. impacts and trends of pharmaceuticals in the
concentrations, mass loading and ecological risks. cia.gov/library/publications/the-world-factbook/. Marine and coastal environment. Phil. Trans. R. Soc.
Environ. Pollut. 182, 402-407. (doi:10.1016/. 110. EFPIA 2013 The pharmaceutical industry in figures. B 369, 20130572. (doi:10.1098/rstb.2013.0572)
envpol.2013.08.004) Key data, 2013, pp. 1—30. Brussels, Belgium: 124. Schmitt H, Roembke J. 2008 The ecotoxicological
100. Elorriaga Y, Marino DJ, Carriquiriborde P, Ronco AE. 2013 uropean Federation of Pharmaceutical Industries effects of pharmaceuticals (antibiotics and
luman pharmaceuticals in wastewaters from urbanized and Associations. antiparasiticides) in the terrestrial environment: a
areas of Argentina. Bull. Environ. Contam. Toxicol. 90, 111. IFPMA 2012 The pharmaceutical industry and global review, pp. 285-303. Berlin, Germany: Springer.
397-400. (doi:10.1007/s00128-012-0919-x) health. Facts and figures 2012, pp. 1-82. Geneva, 125. Fatta-Kassinos D, Kalavrouziotis IK, Koukoulakis PN,
101. Gardner M, Jones V, Comber S, Scrimshaw MD, Switzerland: International Federation of Vasquez MI. 2011 The risks associated with
Coello-Garcia T, Cartmell E, Lester J, Ellor B. 2013 harmaceutical Manufacturers & Associations. wastewater reuse and xenobiotics in the
Performance of UK wastewater treatment works 112. Goswami T, Kannan D, Majumdar S. 2012 Analysis agroecological environment. Sci. Total Environ. 409,
with respect to trace contaminants. Sci. Total of the active pharmaceutical ingredients market: 3555-3563. (doi:10.1016/j.scitotenv.2010.03.036)
Environ. 456-457, 359-369. (doi:10.1016/. Asia-Pacific. Mountain View, CA: Frost & Sullivan. 126. Abdualmjid RJ, Sergi C. 2013 Hepatotoxic
scitotenv.2013.03.088) 113. FAO 2011 Yearbook of fishery statistics. Rome, Italy: botanicals: an evidence-based systematic review.
102. Ortiz de Garcia S, Pinto Pinto G, Garcia Encina P, Irusta United Nations Food and Agriculture Organisation. J. Pharm. Pharm. Sci. 16, 376-404.
Mata R. 2013 Consumption and occurrence of 114. Jimenez B, Asano T. 2008 Water reclamation and reuse 127. Tsai HH, Lin HW, Lu YH, Chen YL, Mahady GB. 2013
pharmaceutical and personal care products in the around the world. In Water reuse: an international survey A review of potential harmful interactions between
aquatic environment in Spain. Sci. Total Environ. 444, of current practice, issues and needs (eds B Jimenez, anticoagulant/antiplatelet agents and Chinese
451-465. (doi:10.1016/.scitotenv.2012.11.057) Asano), pp. 3—26. London, UK: IWA Publishing. herbal medicines. PLoS ONE 8, e64255. (doi:10.
103. Shanmugam G, Sampath S, Selvaraj KK, Larsson DGJ, 115. Vorosmarty CJ et al. 2010 Global threats to human 1371/journal.pone.0064255)